The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
Dale L. Locklair, FAHRMM, CMRP
Vice President of Procurement and Construction
McLeod Health
Florence, SC
White Papers
Incorporating the targets for transformation set by the leader of our organization including unjustified variation, fragmentation of care-giv
White Papers
Increasingly, the hospital and health care delivery system executives are viewing the supply chain as a strategic asset that can be leveraged
White Papers
The initial purpose for developing a socially responsible, closed loop supply chain was to enhance our environmentally sustainable practices by p
White Papers
This paper provides a case-study on what Banner has done to implement and continuously improve this initiative.
White Papers
On August 8, 2011, the Association for Health Care Resource & Materials Management hosted an Executive Thought Leader Event, sponsored by VHA